Healthcare provider profile · identity verified

Stephen Silverstein, DO

Family Practice · POMPANO BEACH, FL · NPI 1326026568

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	576	230
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	316	66
Levothyroxine Sodium	Levothyroxine Sodium	298	89
Alprazolam	Alprazolam	296	88
Atorvastatin Calcium	Atorvastatin Calcium	268	100
Losartan Potassium	Losartan Potassium	263	105
Amlodipine Besylate	Amlodipine Besylate	230	106
Temazepam	Temazepam	212	43
Lorazepam	Lorazepam	177	31
Lisinopril	Lisinopril	168	65
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	161	47
Zolpidem Tartrate	Zolpidem Tartrate	157	41
Tamsulosin Hcl	Tamsulosin Hcl	144	63
Tramadol Hcl	Tramadol Hcl	138	42
Metoprolol Succinate	Metoprolol Succinate	136	51
Albuterol Sulfate Hfa	Albuterol Sulfate	130	54
Ezetimibe	Ezetimibe	127	61
Gabapentin	Gabapentin	124	55
Omeprazole	Omeprazole	112	45
Famotidine	Famotidine	109	57
Potassium Chloride	Potassium Chloride	107	47
Metformin Hcl	Metformin Hcl	104	51
Pantoprazole Sodium	Pantoprazole Sodium	102	49
Clonazepam	Clonazepam	94	17
Trazodone Hcl	Trazodone Hcl	89	41
Hydrochlorothiazide	Hydrochlorothiazide	88	37
Escitalopram Oxalate	Escitalopram Oxalate	87	39
Glipizide Er	Glipizide	81	35
Azithromycin	Azithromycin	79	70
Meloxicam	Meloxicam	79	31
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	77	65
Hydralazine Hcl	Hydralazine Hcl	75	32
Tizanidine Hcl	Tizanidine Hcl	75	32
Furosemide	Furosemide	73	32
Jardiance	Empagliflozin	73	21
Glyxambi	Empagliflozin/Linagliptin	72	17
Pregabalin	Pregabalin	69	19
Metoprolol Tartrate	Metoprolol Tartrate	67	29
Oxybutynin Chloride Er	Oxybutynin Chloride	63	34
Duloxetine Hcl	Duloxetine Hcl	61	31
Clopidogrel	Clopidogrel Bisulfate	60	23
Sildenafil Citrate	Sildenafil Citrate	59	24
Eliquis	Apixaban	57	21
Sertraline Hcl	Sertraline Hcl	56	23
Xarelto	Rivaroxaban	54	19
Fluticasone Propionate	Fluticasone Propionate	48	25
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	48	22
Wixela Inhub	Fluticasone Propion/Salmeterol	48	22
Methylprednisolone	Methylprednisolone	46	42
Carvedilol	Carvedilol	43	17
Ibuprofen	Ibuprofen	43	25
Donepezil Hcl	Donepezil Hcl	41	11
Sumatriptan Succinate	Sumatriptan Succinate	41	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	21
Quetiapine Fumarate	Quetiapine Fumarate	36	13
Finasteride	Finasteride	35	16
Metformin Hcl Er	Metformin Hcl	34	16
Alendronate Sodium	Alendronate Sodium	33	17
Bupropion Xl	Bupropion Hcl	31	12
Diazepam	Diazepam	31	11
Simvastatin	Simvastatin	31	13
Triamcinolone Acetonide	Triamcinolone Acetonide	30	25
Valsartan	Valsartan	30	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	13
Atenolol	Atenolol	28	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Allopurinol	Allopurinol	27	11
Latanoprost	Latanoprost	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Meclizine Hcl	Meclizine Hcl	26	15
Buspirone Hcl	Buspirone Hcl	25	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Nifedipine Er	Nifedipine	23	12
Prednisone	Prednisone	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	19
Dicyclomine Hcl	Dicyclomine Hcl	22	11
Lantus	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Ondansetron Odt	Ondansetron	22	suppressed
Azelastine Hcl	Azelastine Hcl	20	11
Entresto	Sacubitril/Valsartan	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	15
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Baclofen	Baclofen	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	11
Anastrozole	Anastrozole	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Naloxone Hcl	Naloxone Hcl	18	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Terbinafine Hcl	Terbinafine Hcl	17	suppressed
Lithium Carbonate Er	Lithium Carbonate	16	suppressed
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	13
Estradiol	Estradiol	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Glipizide	Glipizide	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Lactulose	Lactulose	13	suppressed
Tadalafil	Tadalafil	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Ozempic	Semaglutide	12	suppressed
Repatha Pushtronex	Evolocumab	12	suppressed
Topiramate	Topiramate	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Fiasp Flextouch	Insulin Aspart (Niacinamide)	11	suppressed
Omnipod Dash Pods (Gen 4)	Insulin Pump Cart,cont Inf,bt	11	suppressed
Tacrolimus	Tacrolimus	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error